Research Calls I
- Upgrades:
- B&G Foods (BGS) upgraded to Neutral from Underweight at Piper Sandler; tgt lowered to $23
- NetApp (NTAP) upgraded to Buy from Hold at Deutsche Bank; tgt lowered to $84
- Nokia (NOK) upgraded to Buy from Neutral at Citigroup
- PBF Energy (PBF) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $57
- Tractor Supply (TSCO) upgraded to Buy from Neutral at BofA Securities; tgt raised to $260
- U.S. Silica (SLCA) upgraded to Outperform from In-line at Evercore ISI; tgt $20
- Downgrades:
- AeroClean Technologies (AERC) downgraded to Hold from Buy at The Benchmark Company
- AstraZeneca (AZN) downgraded to Neutral from Buy at UBS
- Best Buy (BBY) downgraded to Neutral from Buy at BofA Securities
- Chemours (CC) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $44
- Coinbase Global (COIN) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $68
- Envista (NVST) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $46
- Henry Schein (HSIC) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $88
- Hewlett Packard Enterprise (HPE) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $16
- Huntsman (HUN) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $34
- Legacy Housing (LEGH) downgraded to Neutral from Buy at B. Riley Securities; tgt $16
- Netflix (NFLX) downgraded to Sell from Hold at The Benchmark Company; tgt $157
- Omnicom (OMC) downgraded to Hold from Buy at Edward Jones
- Others:
- Ashford (AINC) initiated with an Outperform at Oppenheimer; tgt $28
- Chesapeake Energy (CHK) initiated with an Outperform at Credit Suisse; tgt $115
- Coherus BioSciences (CHRS) initiated with a Neutral at UBS; tgt $7
- Horizon Pharma (HZNP) initiated with a Buy at UBS; tgt $139
- Intra-Cellular Therapies (ITCI) initiated with a Buy at UBS; tgt $75
- Jazz Pharma (JAZZ) initiated with a Buy at UBS; tgt $194
- Marathon Petroleum (MPC) initiated with an Outperform at BMO Capital Markets; tgt $135
- Phillips 66 (PSX) initiated with an Outperform at BMO Capital Markets; tgt $132
- Royalty Pharma (RPRX) resumed with a Buy at UBS; tgt $47
- Teva Pharma (TEVA) resumed with a Neutral at UBS; tgt $10
- Valero Energy (VLO) initiated with a Market Perform at BMO Capital Markets; tgt $155
- Viad Corp initiated with an Outperform at Oppenheimer; tgt $42
- Viatris (VTRS) initiated with a Sell at UBS; tgt $9
